Search

Your search keyword '"Oortwijn, Wija"' showing total 347 results

Search Constraints

Start Over You searched for: Author "Oortwijn, Wija" Remove constraint Author: "Oortwijn, Wija"
347 results on '"Oortwijn, Wija"'

Search Results

12. Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group - Author's reply

15. The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders

18. Towards a Taxonomy of Logic Models in Systematic Reviews and Health Technology Assessments: A Priori, Staged, and Iterative Approaches

19. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

25. Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group

27. Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group

29. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach

30. The VALIDATE handbook

31. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment : The Values in Doing Assessments of Health Technologies Approach

32. Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project

35. 180:oral Designing health benefit packages for universal health coverage – should countries follow a sectoral, incremental or hybrid approach?

36. Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project

38. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

42. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.

43. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.

44. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

45. Core competencies for ethics experts in health technology assessment

49. Core competencies for ethics experts in health technology assessment

Catalog

Books, media, physical & digital resources